Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Model for protecting mouse ulcerative colitis by antibacterial peptide C-BF

A technique for ulcerative colitis and C-BF applied in the field of biomedicine

Inactive Publication Date: 2014-09-10
ZHEJIANG UNIV
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, research on other potential biomedical functions caused by the non-antibacterial activity mechanism of C-BF is still blank

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Model for protecting mouse ulcerative colitis by antibacterial peptide C-BF
  • Model for protecting mouse ulcerative colitis by antibacterial peptide C-BF
  • Model for protecting mouse ulcerative colitis by antibacterial peptide C-BF

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The present invention will be described in detail below in conjunction with the accompanying drawings, and the embodiments are only for describing but not limiting the present invention.

[0027]1: We first confirmed that the antimicrobial peptide C-BF can be absorbed by the peritoneum by using in vivo imaging technology, but it is completely metabolized after remaining in the body for 24 hours. figure 1 In order to confirm the absorption of antimicrobial peptide C-BF into the intestinal cavity by using in vivo imaging technology; from figure 1 We can confirm that C-BF spreads from the intestinal cavity to the whole body in about 10 minutes, but C-BF is metabolized or excreted in the body within 24 hours, so each injection of C-BF should not exceed 24 hours;

[0028] 2: On this basis, we established a mouse model of ulcerative colitis induced by 3% DSS, and the experimental grouping and design were as follows: figure 2 :

[0029] C-BF dose: 5mg / kg mouse body weight, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a model for protecting mouse ulcerative colitis by antibacterial peptide C-BF. Cathelicin-BF has broad-spectrum antibacterial activity, especially for Gram negative bacteria. Inflammatory bowel diseases (IBDs) comprise ulcerative colitis (UC) and Crohn disease (CD), and pathomechanisms of the diseases are not clear yet. A model for inducing the mouse ulcerative colitis by 3% dextran sulphate sodium (DSS) is built; a PBS solution of the C-BF is subjected to rectal injection once per day, the dose of the C-BF is 5mg / kg, the continuous injection time is one week, a mouse is weighed and the body weight data of the mouse is recorded each day during experimental period, and the rectal bleeding and dung forming situations of the mouse are observed. The model is used for making a research on a protection effect on the mouse UC caused by the C-BF.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to the protective effect of C-BF antimicrobial peptide on UC mice. Background technique [0002] IBD is the abbreviation of inflammatory bowel disease, including ulcerative colitis and Crohn's disease, and its pathological mechanism is still unclear. IBD is defined as chronic relapsing gastrointestinal inflammation. Recent studies have shown that various immune, genetic and environmental factors affect the initiation and progression of colitis. The incidence of IBD is higher in Western countries, however, the incidence of IBD in other parts of the world is also increasing due to the influence of Western lifestyle. Ulcerative colitis is a chronic gastrointestinal disease associated with inflammation of the colonic mucosal surface. Human infection with ulcerative colitis may transform into the third most malignant tumor in humans—colorectal cancer. [0003] There are two majo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/09A01K67/027A61D7/00
Inventor 汪以真张海文戎亦骊
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com